These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15201463)

  • 1. Assessment of impaired proteasomal function in a cellular model of polyglutamine diseases.
    Jana NR; Nukina N
    Methods Mol Biol; 2004; 277():287-92. PubMed ID: 15201463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
    Michalik A; Van Broeckhoven C
    Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin, proteasomes, and the aging brain.
    Gray DA; Tsirigotis M; Woulfe J
    Sci Aging Knowledge Environ; 2003 Aug; 2003(34):RE6. PubMed ID: 12944592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
    Amir R; Ciechanover A; Cohen S
    Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The components of the proteasome system and their role in MHC class I antigen processing.
    Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
    Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
    Jana NR; Nukina N
    J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis.
    Kim I; Kim CH; Kim JH; Lee J; Choi JJ; Chen ZA; Lee MG; Chung KC; Hsu CY; Ahn YS
    Exp Cell Res; 2004 Aug; 298(1):229-38. PubMed ID: 15242777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders.
    Amici M; Sagratini D; Pettinari A; Pucciarelli S; Angeletti M; Eleuteri AM
    Arch Biochem Biophys; 2004 Feb; 422(2):168-74. PubMed ID: 14759604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosol-endoplasmic reticulum interplay by Sec61alpha translocon in polyglutamine-mediated neurotoxicity in Drosophila.
    Kanuka H; Kuranaga E; Hiratou T; Igaki T; Nelson B; Okano H; Miura M
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11723-8. PubMed ID: 14504396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
    Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
    Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking a bite: proteasomal protein processing.
    Rape M; Jentsch S
    Nat Cell Biol; 2002 May; 4(5):E113-6. PubMed ID: 11988749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degadration of mismatch repair hMutSalpha heterodimer by the ubiquitin-proteasome pathway.
    Hernandez-Pigeon H; Laurent G; Humbert O; Salles B; Lautier D
    FEBS Lett; 2004 Mar; 562(1-3):40-4. PubMed ID: 15043999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the Qs in the polyglutamine diseases.
    Orr HT
    Genes Dev; 2001 Apr; 15(8):925-32. PubMed ID: 11316786
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain proteasomal function in sporadic Parkinson's disease and related disorders.
    Furukawa Y; Vigouroux S; Wong H; Guttman M; Rajput AH; Ang L; Briand M; Kish SJ; Briand Y
    Ann Neurol; 2002 Jun; 51(6):779-82. PubMed ID: 12112087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
    Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
    Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.